Leukocyte reduction of red cells when transfusing patients with autoimmune hemolytic anemia: a strategy to decrease the incidence of confounding transfusion reactions

1.Sokol RJ, Booker DJ, Stamps R. The pathology of autoimmune hemolytic anemia. J Clin Pathol 1992;45:1074–52.10.1136/jcp.45.12.1047Search in Google Scholar

2.Jefferies LC. Transfusion therapy in autoimmune hemolytic anemia. Hematology/Oncology. Clinics of North America 1994;8:1087–105.10.1016/S0889-8588(18)30123-0Search in Google Scholar

3.Rosenwasser LJ, Joseph BZ. Immunohematologic diseases. JAMA 1992;268:2940–5.10.1001/jama.1992.03490200192024Search in Google Scholar

4.Engelfriet CP, Overbeeke MAM, von dem Borne AEGKr. Autoimmune hemolytic anemia. Seminars in Hematol 1992;29:3–12.Search in Google Scholar

5.Salama A, Berghofer H, Mueller-Eckhardt C. Red blood cell transfusion in warm-type autoimmune haemolytic anemia. Lancet 1992;340:1515–7.10.1016/0140-6736(92)92766-9Search in Google Scholar

6.Walker RH, ed. Technical manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993.Search in Google Scholar

7.Loomis K, Kickler TS, Sears D, Ness PM, Perlstein MT, Johnson R. A simplified radioimmunoassay for antibodies causing immune cytopenia. Am J Clin Pathol 1985;83:12–7.10.1093/ajcp/83.1.123966431Search in Google Scholar

8.von dem Borne AEGKr. Neutrophil alloantigens nature and clinical relevance. Vox Sang 1994;67(Suppl 3):105–12.10.1159/000462712Search in Google Scholar